Lambert, Jo, Carle Paul, Alice Gottlieb, and Yves Poulin. “Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, Versus Placebo and Apremilast in Moderate to Severe Plaque Psoriasis: Analysis of Body Surface Area Involvement in the Phase 3 POETYK PSO-1 and PSO-2 Trials”. SKIN The Journal of Cutaneous Medicine 6, no. 6 (November 16, 2022): s45. Accessed July 3, 2024. https://jofskin.org/index.php/skin/article/view/1800.